Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: A randomized, single-blind, placebo-controlled study

BACKGROUND: Denosumab is a fully human monoclonal antibody against receptor activator of nuclear factor kappa-B ligand, a cytokine essential for the formation, function and survival of osteoclasts. This study assessed the pharmacokinetics, pharmacodynamics, safety and tolerability of single-dose den...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Chen, Qian, Hu, Chaoying, Liu, Yanmei, Song, Rong, Zhu, Wenjing, Zhao, Hongxin, Nino, Antonio, Zhang, Fan, Liu, Yun
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014657/
https://ncbi.nlm.nih.gov/pubmed/29933364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0197984
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires